ArticleNeuron2018
The Role of m
Open access · hybridAbstract read
In one paragraph
Article in Neuron, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 272 papers.
0numbers the graph read from it
0cells of the map it votes in
272citing papers in PubMed
17.0field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
272 citing papers in PubMed, 407 citations in OpenAlex.
- Advanced deep learning strategies in nanopore RNA sequencing.RNA biology · 2026Review
- A DRACH Observed/Expected Metric Reveals the Evolutionary Landscape of Epitranscriptomic Regulation Across Bilateria.Annals of the New York Academy of Sciences · 2026Article
- The YTHDF proteins modulate Alzheimer's disease-associated brain gene signatures.Molecular neurodegeneration · 2026Article
- YTHDF1 modulates CAP1-mediated actin turnover to regulate synaptic function and anxiodepressive-like behaviors.Molecular psychiatry · 2026Article
- mNature reviews. Neuroscience · 2026Review
- The mMolecular psychiatry · 2026Article
- Obesity-related RNA mJournal of neural transmission (Vienna, Austria : 1996) · 2026Article
- Exercise, Demethylase FTO, Neurological Disorders, and Neuropathic Pain: Potential Molecular Mechanisms.CNS neuroscience & therapeutics · 2026Review
- Neuromodulatory role and therapeutic potential of N 6 -methyladenosine RNA methylation in neurodegenerative diseases.Neural regeneration research · 2026Article
- ALKBH3 m1A Demethylase Deficiency Reduces Alzheimer's Amyloid-β Pathology.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Enhancement of Therapeutic mRNA Translation in Cellular Stress Conditions.International journal of molecular sciences · 2026Review
- Single-base resolution atlas reveals moderate conservation and regulatory diversity of m6A modifications across mammals.Nucleic acids research · 2026Article
- Decoding causal m6A: a bioinformatics roadmap for psychiatric disorders.Briefings in bioinformatics · 2026Review
- Emerging roles of RNA mInternational journal of oncology · 2026Review
- Emerging role of N6-methyladenosine (m6A) epitranscriptomic changes in adult anxiety after adolescent alcohol exposure.Neuropharmacology · 2026Article
- Mechanisms of exercise against anxiety disorder: A review of the research progress.Sports medicine and health science · 2026Review
- Rewriting the brain: m6A RNA methylation as an emerging epitranscriptomic regulator in major depressive disorder.Frontiers in molecular neuroscience · 2026Review
- Exercise as a multiscale recalibration of stress-related homeostatic balance.Frontiers in neuroscience · 2026Review
- Sex-dependent serotonergic signaling across development: molecular mechanisms shaping vulnerability to neurodevelopmental and mental disorders.Frontiers in pharmacology · 2026Review
- The expressions and mFrontiers in genetics · 2026Article
212 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
20 authors at 3 institutions in 3 countries.
Mareen EngelDepartment of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich 80804, Germany.
Carola EggertDepartment of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich 80804, Germany.
Paul M KaplickDepartment of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich 80804, Germany.
Matthias EderDepartment of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich 80804, Germany.
Simone RöhDepartment of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich 80804, Germany.
Lisa TietzeDepartment of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich 80804, Germany.
Christian NamendorfClinical Laboratory, Max Planck Institute of Psychiatry, Munich 80804, Germany.
Janine ArlothDepartment of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich 80804, Germany.
Peter WeberDepartment of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich 80804, Germany.
Monika Rex-HaffnerDepartment of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich 80804, Germany.
Shay GeulaDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel.
Mira JakovcevskiDepartment of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich 80804, Germany; Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich 80804, Germany.
Jacob H HannaDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel.
Dena LeshkowitzBioinformatics Unit, Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot 76100, Israel.
Manfred UhrClinical Laboratory, Max Planck Institute of Psychiatry, Munich 80804, Germany.
Carsten T WotjakDepartment of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich 80804, Germany.
Mathias V SchmidtDepartment of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich 80804, Germany.
Jan M DeussingDepartment of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich 80804, Germany.
Elisabeth B BinderDepartment of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich 80804, Germany; Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA.
Alon ChenDepartment of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich 80804, Germany; Department of Neurobiology, Weizmann Institute of Science, Rehovot 76100, Israel. Electronic address: alon_chen@psych.mpg.de.
Max Planck Institute of Psychiatry · DEWeizmann Institute of Science · ILEmory University · US
Funding
No grant is acknowledged in the PubMed record.
Abstract
N
Indexed as
AdenosineAdultAnimalsCell Line, TransformedHumansMaleMethylationMiceMice, Inbred C57BLMice, KnockoutMiddle AgedRNA, MessengerStress, PsychologicalAdenosineN-methyladenosineRNA, MessengerFtom(6)Am(6)Ammajor depressive disorderMettl3post-transcriptional regulationRNA modificationstress
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.